AKT3 and diabetic kidney disease: In conclusion, our findings revealed that circ‐AKT3 inhibited the extracellular matrix accumulation in mesangial cells in diabetic nephropathy through modulating miR‐296‐3p/E‐cadherin signals, which might offer novel potential opportunities for clinical diagnosis targets and therapeutic biomarkers for diabetic nephropathy.